• Eisai gains Henlius therapy; LB Pharma snags $100M in funding
  • GE HealthCare Secures Extended Funding from BARDA
  • Guardant Health
  • Science Corporation
  • Moderna
  • Exact Sciences
  • AstraZeneca
  • Novo Nordisk
BARDA - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

Top Publishers

  • The Verge AI

    The Verge AI

    21 followers

  • TechCrunch AI

    TechCrunch AI

    19 followers

  • Crunchbase News AI

    Crunchbase News AI

    15 followers

  • TechRadar

    TechRadar

    15 followers

  • Hacker News

    Hacker News

    13 followers

See More →

Top Creators

  • Ryan Allis

    Ryan Allis

    209 followers

  • Elon Musk

    Elon Musk

    80 followers

  • Sam Altman

    Sam Altman

    68 followers

  • Mark Cuban

    Mark Cuban

    57 followers

  • Jack Dorsey

    Jack Dorsey

    40 followers

See More →

Top Companies

  • SaasRise

    SaasRise

    211 followers

  • Anthropic

    Anthropic

    40 followers

  • OpenAI

    OpenAI

    22 followers

  • Hugging Face

    Hugging Face

    15 followers

  • xAI

    xAI

    12 followers

See More →

Top Investors

  • Andreessen Horowitz

    Andreessen Horowitz

    16 followers

  • Y Combinator

    Y Combinator

    15 followers

  • Sequoia Capital

    Sequoia Capital

    12 followers

  • General Catalyst

    General Catalyst

    8 followers

  • A16Z Crypto

    A16Z Crypto

    5 followers

See More →
NewsDealsSocialBlogsVideosPodcasts
HomeBARDA
BARDA logo

BARDA

0 followers

About BARDA

BARDA, the Biomedical Advanced Research and Development Authority, accelerates the development, production, and procurement of medical countermeasures to protect the United States from public health emergencies. It coordinates with federal agencies and industry partners to advance vaccines, therapeutics, diagnostics, and medical devices across divisions such as CBRN, influenza and emerging infectious diseases, and DRIVe innovation programs. Based under the U.S. Department of Health and Human Services, BARDA supports national health security through research, development, and partnerships with industry and academia. The organization operates primarily within the United States, with collaborations that extend to domestic manufacturing capacity and regulatory readiness for rapid deployment during emergencies.

Recent News

Eisai Gains Henlius Therapy; LB Pharma Snags $100M in Funding

Recent Deals

GE HealthCare Secures Extended Funding From BARDA

February 17, 2026

Key Team Members

Gary Disbrow

Director of BARDA (as of April 23, 2020)

Rick Bright

Director of BARDA (November 15, 2016 – April 20, 2020)

Carol D. Linden

Inaugural Director (also Principal Deputy Director and Acting Director) of BARDA

Robin A. Robinson

Director of BARDA (April 2008 – November 14, 2016)

Key Facts

HQ Location

Washington, United States

Founded

2006

Employees

51 - 200

Status

Private

Website

https://medicalcountermeasures.gov